|
TRERF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.852100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.476250E-01 |
| Normal-vs-Stage2 |
4.676300E-02 |
| Normal-vs-Stage3 |
3.009900E-02 |
| Normal-vs-Stage4 |
3.964100E-02 |
| Stage1-vs-Stage2 |
2.219800E-01 |
| Stage1-vs-Stage3 |
2.686200E-01 |
| Stage1-vs-Stage4 |
2.321200E-01 |
| Stage2-vs-Stage3 |
6.877200E-01 |
| Stage2-vs-Stage4 |
8.703800E-01 |
| Stage3-vs-Stage4 |
8.093400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.896100E-02 |
| Normal-vs-AfricanAmerican |
7.872000E-02 |
| Normal-vs-Asian |
5.041600E-01 |
| Caucasian-vs-AfricanAmerican |
6.579600E-01 |
| Caucasian-vs-Asian |
1.510550E-01 |
| AfricanAmerican-vs-Asian |
1.519980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.147900E-02 |
| Normal-vs-Female |
1.624970E-01 |
| Male-vs-Female |
2.935600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.845400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.506000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.011810E-02 |
| Normal-vs-Age(81-100Yrs) |
4.830300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.232000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.675000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.272600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.139800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.769600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.995200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.245200E-01 |
| Normal-vs-Grade 2 |
1.897960E-01 |
| Normal-vs-Grade 3 |
1.392220E-02 |
| Normal-vs-Grade 4 |
7.228200E-02 |
| Grade 1-vs-Grade 2 |
1.367160E-01 |
| Grade 1-vs-Grade 3 |
3.793800E-02 |
| Grade 1-vs-Grade 4 |
6.806100E-02 |
| Grade 2-vs-Grade 3 |
9.134000E-02 |
| Grade 2-vs-Grade 4 |
3.450200E-01 |
| Grade 3-vs-Grade 4 |
7.890600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.504600E-01 |
| Normal-vs-ccB subtype |
9.675800E-02 |
| ccA subtype-vs-ccB subtype |
5.021600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.797600E-02 |
| Normal-vs-N1 |
5.566800E-01 |
| N0-vs-N1 |
7.990600E-01 |
|
|
